About Board BasicsSM 3

This app, designed to help you prepare for high-stakes examinations, is an enhancement to MKSAP® 16. It may be downloaded to all of your devices, including iPhones, iPads, Android smartphones or tablets, and Windows or MacOS notebooks and laptops. The app is free to users of MKSAP 16 Digital who have been granted access to Board Basics 3.

MKSAP 16 Online, which is available at mksap16.acponline.org, provides text, questions, answers, custom quizzes, a learning documentation tool, peer comparison scores, content-searching capability, links between questions and text, and the ability to submit for CME credits, Maintenance of Certification points, and Continuous Professional Development credits.

Editor's Letter
Committee/Disclosures
Publisher's Information
License Agreement: Board Basics 3 Apps

Disclosure Policy

It is the policy of the American College of Physicians (ACP) to ensure balance, independence, objectivity, and scientific rigor in all its educational activities. To this end, and consistent with the policies of the ACP and the Accreditation Council for Continuing Medical Education (ACCME), contributors to all ACP continuing medical education activities are required to disclose all relationships with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. Contributors are required to use generic names in the discussion of therapeutic options and are required to identify any unapproved, off-label, or investigative use of commercial products or devices. Where a trade name is used, all available trade names for the same product type are also included. If trade-name products manufactured by companies with whom contributors have relationships are discussed, contributors are asked to provide evidence-based citations in support of the discussion. The information is reviewed by the committee responsible for producing this text. If necessary, adjustments to topics or contributors' roles in content development are made to balance the discussion. Further, all readers of this text are asked to evaluate the content for evidence of commercial bias so that future decisions about content and contributors can be made in light of this information.

Resolution of Conflicts

To resolve all conflicts of interest and influences of vested interests, the ACP precluded members of the content-creation committee from deciding on any content issues that involved generic or trade-name products associated with proprietary entities with which these committee members had relationships. In addition, content was based on best evidence and updated clinical care guidelines, when such evidence and guidelines were available. Contributors' disclosure information can be found with the list of committees and those of ACP principal staff listed in this document.